Galaxy Medicare (NSE:GML) ROE % Adjusted to Book Value: 11.31% (As of Mar. 2026)


NSE:GML Galaxy Medicare Ltd NSE:GML
19 GF Score
Price ₹19.00
! 2 Warning Signs
View Full Analysis

What is Galaxy Medicare ROE % Adjusted to Book Value?

Galaxy Medicare NSE:GML +4.97% 19 ROE % Adjusted to Book Value is 11.31% as of Mar. 2026. GuruFocus rates NSE:GML with a GF Score™ of 19/100. The stock has 2 warning signs investors should review.

Galaxy Medicare's ROE % for the quarter that ended in Mar. 2026 was 7.01%. Galaxy Medicare's PB Ratio for the quarter that ended in Mar. 2026 was 0.62. Galaxy Medicare's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 11.31%.

Galaxy Medicare ROE % Adjusted to Book Value Related Terms

Galaxy Medicare ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Galaxy Medicare's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galaxy Medicare ROE % Adjusted to Book Value Chart

Galaxy Medicare Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
ROE % Adjusted to Book Value
0.00 0.00 0.00 0.00 17.10

Galaxy Medicare Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial 0.00 0.00 0.00 10.16 11.31

NSE:GML vs ISRG, BDX, MDLN: ROE % Adjusted to Book Value Comparison

For the Medical Instruments & Supplies subindustry, Galaxy Medicare's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galaxy Medicare ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Galaxy Medicare's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Galaxy Medicare's ROE % Adjusted to Book Value falls into.


NSE:GML
19GF Score
Galaxy Medicare Ltd NSE:GML
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galaxy Medicare ROE % Adjusted to Book Value Calculation

Galaxy Medicare's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=10.60% / 0.62
=17.10%

Galaxy Medicare's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=7.01% / 0.62
=11.31%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 11.31% mean?
Galaxy Medicare (NSE:GML) has a ROE % Adjusted to Book Value of 11.31% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Galaxy Medicare and its competitors.
Is Galaxy Medicare's ROE % Adjusted to Book Value too high?
Galaxy Medicare's current ROE % Adjusted to Book Value is 11.31%. Overall, Galaxy Medicare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Galaxy Medicare's ROE % Adjusted to Book Value compare to ISRG and BDX?
Galaxy Medicare's ROE % Adjusted to Book Value of 11.31% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Galaxy Medicare and its competitors. Galaxy Medicare's current ROE % Adjusted to Book Value is 11.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galaxy Medicare stock overvalued right now?
Galaxy Medicare (NSE:GML) has a current ROE % Adjusted to Book Value of 11.31%. The current ROE % Adjusted to Book Value is 11.31%. Galaxy Medicare's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Galaxy Medicare (NSE:GML), the current ROE % Adjusted to Book Value is 11.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galaxy Medicare Business Description

Address Plot No-2, Zone D, Phase A, Mancheswar Industrial Estate, Khurda, Bhubaneswar, OR, IND, 751010
Galaxy Medicare Ltd is engaged into the manufacturing, trading and exporting of Medical Devices, Plasters of Paris Bandages (POP Bandage) and Other surgical dressings in India. Its business encompass: Manufacturing and Branding of its own products under its flagship brands i.e. POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE GYPSONET, GYPSOCHLOR, FIXCAN ETC.
19GF Score

Get the complete analysis for NSE:GML

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹19.00
Price